Abstract:Cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy (CADASIL) is caused by a mutation on the NOTCH3 gene. The pathological driver behind this disease is the loss of vascular smooth muscle cells (VSMCs) in small blood vessels and subsequent fibrotic thickening of the vessel, causing stenosis. Although a great deal of knowledge has been accumulated through CADASIL research, more information is needed to fully grasp the pathological mechanisms as well as understand disease progression. We have focused on the effects of NOTCH3 mutation on VSMCs and identified several novel actors in disease progression. In our initial study, we investigated factors playing a role in the VSMC proliferative rate. We found that VSMCs carrying a CADASIL mutation express higher levels of TGFβ. This elevated cytokine secretion by CADASIL VSMCs had an inhibitory proliferative effect on not only these cells, but also cells in their vicinity. This phenotype was rescued by adding neutralizing TGFβ antibody to the growth media, which increased CADASIL VSMC proliferation rate to that of control VSMCs, while having a minimal effect on control VSMC proliferation rate. One of the initial events in CADASIL disease progression is NOTCH3 aggregation and accumulation. In our next study, we focused on degradation of aggregated NOTCH3 via autophagy processes. After confirming that NOTCH3 is aggregated and accumulated in our cell line, we further tested the autophagy process in these cells. We discovered that the autophagy process in CADASIL VSMCs is interrupted and, upon further investigation, found that this could be due to a dysfunction in fusion of the autophagosome and lysosome. Next, we investigated the nutritional requirements in CADASIL VSMCs compared to control VSMCs. One of the most readily available forms of nutrients in myocytes is glucose. Hence, we examined glucose transporter expression in CADASIL VSMCs compared to control VSMCs. CADASIL VSMC glucose transporters were significantly down regulated and this down regulation had a negative functional effect such that CADASIL VSMCs were unable to take up glucose as avidly as control VSMCs. Adding insulin to the media only moderately increased glucose uptake in CADASIL VSMCs since Glut 4 was the only insulin-dependent glucose transporter that was down regulated (other glucose transporters were also down regulated, but they were insulinindependent). VSMCs in CADASIL are frail and less resistant to stress. Based on this fact, we hypothesized that they may secret inflammatory cytokines and thereby affect their neighboring cells in paracrine fashion. Measuring inflammatory cytokine gene expression, we discovered that most of them were up regulated, which translated to an increased amount of protein synthesis. In this study, we have implicated inflammation as a pathological driver in CADASIL. Dampening of this inflammatory response may slow the rate of VSMC loss and, consequently, disease progression. LIST OF SCIENTIFIC PAPERS I. Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression II. Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells III. Disrupted Glucose metabolism in Brain Myocytes in CADASIL IV. CADASIL mutation in vascular smooth muscle cells cause high inflammatory response in CADASIL

Impaired intracellular Ca 2+ signaling contributes to age-related cerebral small vessel disease in Col4a1 mutant mice

Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome

Collagen IV deficiency causes hypertrophic remodeling and endothelium-dependent hyperpolarization in small vessel disease with intracerebral hemorrhage

Microvascular damage, neuroinflammation and extracellular matrix remodeling in Col18a1 knockout mice as a model for early cerebral small vessel disease

Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration.

MYPT1SMKO Mice Function As a Novel Spontaneous Age- and Hypertension-Dependent Animal Model of CSVD

Oligomerization, trans-reduction, and instability of mutant NOTCH3 in inherited vascular dementia

CADASIL mutations sensitize the brain to ischemia via spreading depolarizations and abnormal extracellular potassium homeostasis

Vascular smooth muscle cell-specific Igf1r deficiency exacerbates the development of hypertension-induced cerebral microhemorrhages and gait defects

Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease

CADASIL : a pure model for studying cerebral small vessel disease

Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway

Age-related decline in oligodendrogenesis retards white matter repair in mice

Cerebral Microvascular Density, Permeability of the Blood-Brain Barrier, and Neuroinflammatory Responses Indicate Early Aging Characteristics in a Marfan Syndrome Mouse Model

Gliovascular Disruption and Cognitive Deficits in a Mouse Model with Features of Small Vessel Disease

IGF1R deficiency in vascular smooth muscle cells impairs myogenic autoregulation and cognition in mice

ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics

Stem cell factor and granulocyte colony-stimulating factor exhibit therapeutic effects in a mouse model of CADASIL

Early molecular layer interneuron hyperactivity triggers Purkinje neuron degeneration in SCA1

Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (C-Jun N-Terminal Kinase).

Col1a2-Deleted Mice Have Defective Type I Collagen and Secondary Reactive Cardiac Fibrosis with Altered Hypertrophic Dynamics